Biomedical and Chemical Engineering Graduate Seminar
Leveraging semiconductors for biotech innovation - spinning out a venture-backed company, CytoTronics, from electronic-bio interface innovation
Presented By
Dr. Jeffrey Abbott, CEO and Co-Founder
CytoTronics
Abstract:
In this talk, I will share my journey from RIT, where I specialized in CMOS integrated circuit design, to my work at Harvard, where I applied semiconductor technology to biological systems. This combination of disciplines led to the creation of CytoTronics, a venture-backed company focused on cutting-edge bioelectronic systems. I will discuss how we leverage semiconductor technologies to develop a high-resolution, multi-modal platform capable of real-time electrical imaging of cells. Our technology is transforming live-cell analysis, with applications in drug discovery and cell-based assays. Additionally, I’ll touch on the challenges of transitioning from academia to entrepreneurship and the key steps in spinning out a research-based venture. Attendees can expect insights into the intersection of technology and biology, as well as lessons learned from building a startup in this exciting field.
Short Bio:
Jeffrey Abbott is the Co-founder and CEO of CytoTronics, a venture-backed startup focused on bioelectronic systems for advanced live-cell analysis. Jeffrey holds a PhD in Engineering Sciences from Harvard University, where he pioneered semiconductor-based tools for biological research. Prior to Harvard, he earned his MS and BS in Electrical Engineering from RIT, specializing in CMOS integrated circuit design. Jeffrey's work has been recognized with several awards, including the R&D 100 Award, and he has published extensively on semiconductor-bio interfaces. Under his leadership, CytoTronics is poised to deliver groundbreaking tools for cell biology and drug discovery.
Event Snapshot
When and Where
Who
Open to the Public
Interpreter Requested?
No